- CVS Health said it is offering an online appointment through MinuteClinic for $29 for certain GLP-1 therapies, with the company saying it is possible that GLP-1 therapy could be prescribed based on a clinical assessment.
- The program is expected to be available in the United States following regulatory approval, with the company stating that it will be offered to patients aged 18 to 64.
- Shortly after CVS Health announced the program for 2026, Aetna said its medical loss ratio would be 87.4%.
CVS Health said it is launching an online appointment service with a price of $29 at MinuteClinic for certain GLP-1 therapies. The company said in a filing that it plans to offer the service in the United States, and that the service may be able to prescribe GLP-1 therapy based on a clinical assessment.
In its filing, CVS Health said it expects the program to improve its ability to control costs associated with GLP-1 therapies. Following the launch across all states in the United States, the program is expected to have a similar impact on its 18–64-year-old customer base, which plans to be able to prescribe GLP-1 therapy based on a clinical assessment.
In its filing, CVS Health said it would not be able to predict the impact of the program on third-party customer results. The company said it expects that the program will be able to increase the number of customers with a higher risk of developing medical conditions.
CVS Health forecast adjusted profit per share (adjusted profit per share) of $7.90–$8.10 for 2026, compared with $7.30–$7.50 previously. LSEG data show that analysts expect the profit per share for 2026 to be $7.45.
Another factor that CVS Health cited was a slower decline in adjusted profit: the company expects adjusted profit to rise by $2.58 per share versus $1.85. The company also said that, in 2024, Aetna’s medical loss ratio (medical loss ratio) was 87.4%, compared with 89.9% a year earlier, and 90.03% for the year before that.
In a statement to CVS Health’s shareholders, the company said it expects to keep its loss ratio in line with the results in Aetna, with the company citing Star ratings, which it said would affect the results. The company also said it expects that its Medicare program for other plans for people aged 65 will have a similar impact on Star ratings.